- Home
- SGD vs HSDT Comparison
SGD vs HSDT Comparison
Compare SGD & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGD
- HSDT
- Stock Information
- Founded
- SGD 2021
- HSDT 2014
- Country
- SGD United States
- HSDT United States
- Employees
- SGD N/A
- HSDT N/A
- Industry
- SGD
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SGD
- HSDT Health Care
- Exchange
- SGD Nasdaq
- HSDT Nasdaq
- Market Cap
- SGD 2.6M
- HSDT 2.9M
- IPO Year
- SGD N/A
- HSDT N/A
- Fundamental
- Price
- SGD $1.28
- HSDT $0.54
- Analyst Decision
- SGD
- HSDT Buy
- Analyst Count
- SGD 0
- HSDT 2
- Target Price
- SGD N/A
- HSDT $24.00
- AVG Volume (30 Days)
- SGD 209.2K
- HSDT 241.1K
- Earning Date
- SGD 01-01-0001
- HSDT 03-27-2025
- Dividend Yield
- SGD N/A
- HSDT N/A
- EPS Growth
- SGD N/A
- HSDT N/A
- EPS
- SGD N/A
- HSDT N/A
- Revenue
- SGD $173,188.00
- HSDT $502,000.00
- Revenue This Year
- SGD N/A
- HSDT N/A
- Revenue Next Year
- SGD N/A
- HSDT $8.97
- P/E Ratio
- SGD N/A
- HSDT N/A
- Revenue Growth
- SGD N/A
- HSDT N/A
- 52 Week Low
- SGD $1.26
- HSDT $0.37
- 52 Week High
- SGD $53.80
- HSDT $7.19
- Technical
- Relative Strength Index (RSI)
- SGD 33.74
- HSDT 43.07
- Support Level
- SGD $1.33
- HSDT $0.50
- Resistance Level
- SGD $1.46
- HSDT $0.60
- Average True Range (ATR)
- SGD 0.16
- HSDT 0.06
- MACD
- SGD 0.01
- HSDT -0.01
- Stochastic Oscillator
- SGD 3.74
- HSDT 15.87
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.